485 related articles for article (PubMed ID: 32446298)
1. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
Trials; 2020 May; 21(1):415. PubMed ID: 32446298
[TBL] [Abstract][Full Text] [Related]
2. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
Kristensen AMD; Munkhaugen J; Halvorsen S; Olsen MH; Bakken A; Sehested TSG; Ruddox V; Lange T; Fagerland MW; Torp-Pedersen C; Prescott E; Atar D
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):175-183. PubMed ID: 38017624
[TBL] [Abstract][Full Text] [Related]
3. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
Munkhaugen J; Ruddox V; Halvorsen S; Dammen T; Fagerland MW; Hernæs KH; Vethe NT; Prescott E; Jensen SE; Rødevand O; Jortveit J; Bendz B; Schirmer H; Køber L; Bøtker HE; Larsen AI; Vikenes K; Steigen T; Wiseth R; Pedersen T; Edvardsen T; Otterstad JE; Atar D
Am Heart J; 2019 Feb; 208():37-46. PubMed ID: 30530121
[TBL] [Abstract][Full Text] [Related]
4. Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.
Nordenskjöld AM; Agewall S; Atar D; Baron T; Beltrame J; Bergström O; Erlinge D; Gale CP; López-Pais J; Jernberg T; Johansson P; Ravn-Fisher A; Reynolds HR; Somaratne JB; Tornvall P; Lindahl B
Am Heart J; 2021 Jan; 231():96-104. PubMed ID: 33203618
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X; Raposeiras-Roubin S; Latini R; Dominguez-Rodriguez A; Barrabés JA; Sánchez PL; Anguita M; Fernández-Vázquez F; Pascual-Figal D; De la Torre Hernandez JM; Ferraro S; Vetrano A; Pérez-Rivera JA; Prada-Delgado O; Escalera N; Staszewsky L; Pizarro G; Agüero J; Pocock S; Ottani F; Fuster V; Ibáñez B;
Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):291-301. PubMed ID: 34351426
[TBL] [Abstract][Full Text] [Related]
6. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
7. βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial.
Silvain J; Cayla G; Ferrari E; Range G; Puymirat E; Delarche N; Collet JP; Dumaine R; Slama M; Payot L; Kasty ME; Aacha K; Vicaut E; Montalescot G;
Am Heart J; 2023 Apr; 258():168-176. PubMed ID: 36682596
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
Hong J; Barry AR
Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
[TBL] [Abstract][Full Text] [Related]
9. Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI).
Yndigegn T; Lindahl B; Alfredsson J; Benatar J; Brandin L; Erlinge D; Haaga U; Held C; Johansson P; Karlström P; Kellerth T; Marandi T; Mars K; Ravn-Fischer A; Sundström J; Östlund O; Hofmann R; Jernberg T
Eur Heart J Cardiovasc Pharmacother; 2023 Feb; 9(2):192-197. PubMed ID: 36513329
[TBL] [Abstract][Full Text] [Related]
10. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
Yndigegn T; Lindahl B; Mars K; Alfredsson J; Benatar J; Brandin L; Erlinge D; Hallen O; Held C; Hjalmarsson P; Johansson P; Karlström P; Kellerth T; Marandi T; Ravn-Fischer A; Sundström J; Östlund O; Hofmann R; Jernberg T;
N Engl J Med; 2024 Apr; 390(15):1372-1381. PubMed ID: 38587241
[TBL] [Abstract][Full Text] [Related]
11. The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
Wen XS; Luo R; Liu J; Liu ZQ; Zhang HW; Hu WW; Duan Q; Qin S; Xiao J; Zhang DY
Clin Cardiol; 2022 May; 45(5):509-518. PubMed ID: 35246866
[TBL] [Abstract][Full Text] [Related]
12. Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study.
Wen XS; Luo R; Liu J; Duan Q; Qin S; Xiao J; Zhang DY
BMC Cardiovasc Disord; 2022 Apr; 22(1):193. PubMed ID: 35473676
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
Maqsood MH; Alam M; Atar D; Birnbaum Y
J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
[TBL] [Abstract][Full Text] [Related]
14. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials.
Houghton T; Freemantle N; Cleland JG
Eur J Heart Fail; 2000 Sep; 2(3):333-40. PubMed ID: 10938496
[TBL] [Abstract][Full Text] [Related]
15. β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study.
Hagsund T; Olsson SE; Smith JG; Madsen Hardig B; Wagner H
BMC Cardiovasc Disord; 2020 Apr; 20(1):165. PubMed ID: 32272880
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.
Bauersachs J; Solomon SD; Anker SD; Antorrena-Miranda I; Batkai S; Viereck J; Rump S; Filippatos G; Granzer U; Ponikowski P; de Boer RA; Vardeny O; Hauke W; Thum T
Eur J Heart Fail; 2024 Mar; 26(3):674-682. PubMed ID: 38269451
[TBL] [Abstract][Full Text] [Related]
17. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
18. Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ; Park CS; Park JJ; Lee HY; Kang SM; Yoo BS; Jeon ES; Hong SK; Shin JH; Kim MA; Park DG; Kim EJ; Hong SJ; Kim SY; Kim JJ
Trials; 2018 Feb; 19(1):103. PubMed ID: 29433525
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
[TBL] [Abstract][Full Text] [Related]
20. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Dargie HJ
Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
